GlassScriptPhysician profile
Ray J Hsiao
NPI 1164507869
$21,025.29
in general payments reported to CMS, 2019-2025
50 companies · $2,437 in 2025
The $2,437 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,443 · 2020: $4,192 · 2021: $3,731 · 2022: $2,257 · 2023: $2,603 · 2024: $2,362 · 2025: $2,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,222 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,222.46 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,454.26 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $2,641.58 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Gilead Sciences, INC. | $1,540.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $1,376.35 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,290.29 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $1,114.98 | 2019-2025 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $1,110.16 | 2019-2021 | |
| Amgen INC. | $1,053.07 | 2019-2025 | Evenity, Prolia, Repatha |
| Astellas Pharma US INC | $812.94 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $723.36 | 2019-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $685.30 | 2021-2025 | |
| Lilly USA, LLC | $511.61 | 2019-2024 | Zepbound, Mounjaro, Jardiance |
| Esperion Therapeutics, INC. | $493.48 | 2020-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $426.51 | 2019-2025 | |
| Pfizer INC. | $421.70 | 2019-2024 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $397.04 | 2020-2025 | Linzess |
| Kowa Pharmaceuticals America, INC. | $331.44 | 2019-2025 | Zoryve, Seglentis, Livalo |
| Abbvie INC. | $313.06 | 2020-2025 | |
| Radius Health, INC. | $249.91 | 2020-2025 | Tymlos |
| Scilex Pharmaceuticals INC. | $199.13 | 2019-2020 | |
| Vivus LLC | $168.33 | 2019-2025 | Pancreaze |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.66 | 2020-2025 | Xifaxan |
| Allergan, INC. | $118.98 | 2019-2020 | |
| Alvogen INC | $116.68 | 2022-2025 | Teriparatide |
| Abbott Laboratories | $105.35 | 2024-2025 | Freestyle Libre 3 |
| Verona Pharma, INC. | $103.40 | 2025 | Ohtuvayre |
| Ucb, INC. | $102.04 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $99.34 | 2023-2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $95.48 | 2024 | Voquezna |
| Sun Pharmaceutical Industries INC. | $76.34 | 2021 | |
| Eisai INC. | $70.76 | 2022-2025 | |
| Exact Sciences Corporation | $66.99 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $66.78 | 2021-2025 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $62.77 | 2020-2022 | |
| Nestle Healthcare Nutrition INC. | $58.74 | 2021 | |
| Arbor Pharmaceuticals, INC. | $58.12 | 2020-2021 | |
| Hikma Pharmaceuticals USA | $50.18 | 2020-2021 | |
| Corium, LLC | $48.02 | 2022-2023 | Adlarity |
| Sunovion Pharmaceuticals INC. | $39.01 | 2019 | |
| Eyevance Pharmaceuticals LLC | $29.06 | 2021 | |
| Bioventus LLC | $26.60 | 2023 | Supartz Fx Sodium Hyaluronate |
| Avanos Medical | $24.42 | 2023 | Trivisc Sodium Hyaluronate |
| Depuy Synthes Sales INC. | $23.96 | 2024 | Orthovisc |
| Biogen, INC. | $23.92 | 2021 | |
| Zimmer Biomet Holdings, INC. | $20.58 | 2025 | Visco-3 Sodium Hyaluronate |
| Dermira, INC. | $16.82 | 2020 | |
| Redhill Biopharma INC. | $15.47 | 2020 | |
| Avanir Pharmaceuticals, INC. | $14.42 | 2022 | |
| Seqirus USA INC | $13.08 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Takeda Pharmaceuticals U.S.A., INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Hsiao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.